Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2017 07:02 ET | Source: Photocure ASA

Photocure ASA: Presentation at the Carnegie Nordic Healthcare Day, New York

Oslo, Norway, December 5, 2017 - Photocure ASA (OSE: PHO) announced today that the company will present at the Carnegie Nordic Healthcare Day, New York, on 5 December 2017. Presenter will be Ambaw...
December 01, 2017 02:32 ET | Source: Photocure ASA

Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New data presented at Society of Urological Oncology

Oslo, Norway, December 1, 2017 Photocure ASA (OSE: PHO) announced today that more detailed data from the Phase 3 study data was presented at the prestigious Society of Urologic Oncology, Annual...
November 09, 2017 06:55 ET | Source: Photocure ASA

Photocure ASA: Clinical and cost impact analysis shows beneficial impact of replacing current surgical modalities with Cevira®

A poster demonstrating the clinical and cost impact of Cevira® was presented at the ISPOR European congress in Glasgow, Scotland, November 4-8, 2017. The budget impact model from a US payer...
November 08, 2017 01:15 ET | Source: Photocure ASA

Photocure ASA: Results for the third quarter of 2017

Oslo, Norway, 7 November 2017: Photocure ASA (OSE:PHO), today reported a revenue growth of 45% for the important US market in the third quarter of 2017, contributing to Hexvix/Cysview revenues of...
November 02, 2017 03:07 ET | Source: Photocure ASA

Photocure ASA:U.S. CMS improves reimbursement for Blue Light Cystoscopy with Cysview®

Oslo, Norway, November 2,2017: Photocure ASA (OSE: PHO), announced today that the United States Centers for Medicare & Medicaid Services (CMS) has issued a Final Rule stating that it will...
October 31, 2017 06:08 ET | Source: Photocure ASA

Photocure ASA: Presentation of the third quarter 2017 results

Photocure will present its third quarter report on Wednesday 8 November 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will...
October 23, 2017 06:01 ET | Source: Photocure ASA

Photocure ASA: BLC(TM) with Cysview®/Hexvix® real World Data presented at the Société Internationale d'Urologie 2017 Annual meeting

Oslo, Norway, October 23, 2017 Photocure ASA announced that new data from the Blue Light Cystoscopy (BLC(TM)) with Cysview®/Hexvix® registry study were presented at the 37th Société Internationale...
October 18, 2017 02:15 ET | Source: Photocure ASA

Photocure ASA: FDA grants priority review for Cysview® supplemental New Drug Application (sNDA)

Oslo, Norway, October 18, Photocure ASA (OSE: PHO) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Cysview® on a...
August 23, 2017 01:12 ET | Source: Photocure ASA

Photocure ASA: Results for second quarter and first half year of 2017

Oslo, Norway, 23 August 2017: Photocure ASA (OSE:PHO), today reported a Hexvix/Cysview revenue growth of 10% to NOK 37.6 million in the second quarter of 2017 (Q2 2016: NOK 34.2), with an EBITDA of...
August 18, 2017 02:47 ET | Source: Photocure ASA

Photocure ASA: Blue Light Cystoscopy with Hexvix® reduces recurrence rate at 3 years in real-life experience study

Oslo, Norway, August 18, 2017: Photocure ASA (OSE: PHO) today announced that a prospective controlled study investigating the introduction of Blue Light Cystoscopy (BLC(TM)) with Hexvix® at first...